Skip to main content
. 2021 May 7;35:100845. doi: 10.1016/j.eclinm.2021.100845

Table 1.

Sociodemographic and clinical characteristics for the total sample, by race, and by ADL subgroup status.

Total Sample (N = 79) White Participants (n = 59) Black Participants (n = 13) Non-White/ Non-Black (n = 7) ADL Non-Risk (n = 40) ADL Risk Group (n = 39)
Age in years: Mean (SD) 63·1 (5·1) 63·3 (4·9) 64·1 (5·9) 59·7 (3·7) 64·3 (5·1) 61·9 (4·8)
Education in years: Mean (SD) 15·8 (2·5) 16·3 (2·3) 14·5 (2·4) 13·7 (2·1) 16·5 (2·5) 15·0 (2·2)
% Male 95% 98% 77% 100% 95% 95%
% MSM 79% 88% 31% 86% 83% 74%
Nadir CD4 T-cell count: Median (IQR) 183 (219) 180 (159) 217 (296) 100 (288) 199 (176) 128 (262)
Current CD4+ T-cell count: Median (IQR) 620 (382) 578 (321) 731 (555) 781 (902) 643 (333) 540 (438)
Plasma HIV RNA suppression 100% 100% 100% 100% 100% 100%
WRAT-4 T-score: Mean (SD) 50 (10) 51·50 (8·86) 42 (14·98) 48·81 (2·43) 52·8 (9·9) 46·7 (9·2)
Geriatric Depression Scale: Mean (SD) 9·4 (6·3) 9·9 (6·7) 7·8 (6·0) 9·0 (4·0) 9·5 (6·1) 9·4 (6·7)

MSM = Men who have sex with men. SD = Standard deviation. IQR = Interquartile Range. One participant reported a history of learning difficulty, and one participant reported current use of an opioid medication for chronic pain. Non-White/Non-Black subgroup was comprised of the following: Native Hawaiian or Pacific Islander (n = 2), Asian (n = 1), and (n = 4) endorsed “other”.